Skuldtech France (Skuldtech) is a biotechnology company. The company discovers bio-markers and develops diagnostics tests. Its genomic bio-markers could be applied in several activities including: disease detection and classification, patient stratification, companion diagnosis, disease prognosis. The company provides services such as transcriptomics, genomics, pharmacogenomics, drug re-purposing and training. Skuldtech provides transcriptomic services based on gene expression technologies, sequencing, qRT-PCR, and bioinformatic data analysis. It provides a range of products and services based on its genomic platform. The company has developed a gene profiling platform using digital gene expression (SAGE-like) method, new generation sequencing (NGS) technologies, bioinformatic and bio-statistical programs. It partners with EU, the FUI, Oseo and others to support its research operations. Skuldtech is headquartered in Montpellier, France.
Full Report Details at
- http://www.fastmr.com/prod/643028_skuldtech_france_product_pipeline_analysis_2013.aspx?afid=303
This report is a source for data, analysis and actionable intelligence on the Skuldtech France portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
* Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
* Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
* Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
* Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
* Data on relevant clinical trials and product patent details, wherever applicable.
* Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Get this Report
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
You may also be interested in these related reports:
- GE Healthcare - Product Pipeline Analysis , 2013 Update
- Philips Healthcare - Product Pipeline Analysis, 2013 Update
- Boston Scientific Corporation (BSX) - Product Pipeline Analysis, 2013 Update
- St. Jude Medical, Inc. (STJ) - Product Pipeline Analysis, 2013 Update
- Siemens Healthcare - Product Pipeline Analysis, 2013 Update
Recent Study: Skuldtech France - Product Pipeline Analysis, 2013 Update
Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Name: Bill Thompson
Contact Email: press@fastmr.com